The positive expression rate of TMEFF1 in the lymph node metastasis group was 85.7% (24/28), which was significantly higher than that in the non-lymph node metastasis group (45.0%; 18/40; P < 0.001). This evidence concerns the gene TMEFF1 and metastatic malignant neoplasm in the lymph nodes.